Rigel Pharmaceuticals, Inc. (RIGL) Social Stream



Rigel Pharmaceuticals, Inc. (RIGL): $3.74

-0.15 (-3.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About RIGL

$RIGL Let's not forget the NIH's wonderful research into NETosis, fostamatinib and C19.

NIH doctor discussing NETosis: "Some preliminary data suggests using a tyrosine kinase inhibitor (fostamatinib) we can fully reverse these phenotypes which is something that has us excited to study these implications moving forward."
https://www.youtube.com/watch?v=YcvJ2kEGOZ0
Lead investigator: Just out in JID, @dr_mjramos and I along with others show that R406 (fostamatinib) can inhibit NETs when neutrophils are stimulated with COVID-19 plasma.
https://twitter.com/JeffreyStrichMD/status/1342097212151648256
NIH lead study publication: This is the first report to identify that R406, a potent SYK inhibitor and the metabolically active component of fostamatinib, inhibits NETosis among healthy donor neutrophils stimulated with COVID-19 patient plasma.
https://academic.oup.com/jid/article/223/6/981/6046406

This, along with the inhibition of the cytokine storm and other hyper-inflammatory processes put us miles ahead of any other therapeutic for C19 and is why we'll get a EUA off an n=59.
tomengine, published July 28, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0779 seconds.